Assembly biosciences posts q3 loss per share of $0.96

Assembly biosciences reports third quarter 2019 financial results and recent highlights.q3 loss per share $0.96.q3 earnings per share estimate $-0.93 -- refinitiv ibes data.assembly biosciences - cash, cash equivalents, marketable securities were about $156.9 million as of september 30 versus about $173.8 million as of june 30, 2019.quarter-end cash position is projected to fund operations into 2021.assembly biosciences - revenue from collaborative research were about $4.2 million for 3 months ended sept 30, compared to $4.3 million for same period in 2018.
ASMB Ratings Summary
ASMB Quant Ranking